标题
Effects of interleukin-2 in immunostimulation and immunosuppression
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 217, Issue 1, Pages -
出版商
Rockefeller University Press
发表日期
2019-10-15
DOI
10.1084/jem.20191247
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- De novo design of potent and selective mimics of IL-2 and IL-15
- (2019) Daniel-Adriano Silva et al. NATURE
- IL2/anti-IL2 complex combined with CTLA-4, but not PD-1, blockade rescues antitumor NK cell function by regulatory T-cell modulation
- (2019) Pamela Caudana et al. Cancer Immunology Research
- Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2
- (2019) Lei Zhou et al. NATURE
- Systemic IL-2/anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells
- (2018) P. L. Smaldini et al. ALLERGY
- Signaling and Function of Interleukin-2 in T Lymphocytes
- (2018) Sarah H. Ross et al. Annual Review of Immunology
- Cancer immunotherapy beyond immune checkpoint inhibitors
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells
- (2018) Tania Carmenate et al. JOURNAL OF IMMUNOLOGY
- A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
- (2018) Eleonora Trotta et al. NATURE MEDICINE
- Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
- (2018) Jonathan T. Sockolosky et al. SCIENCE
- TCR Signaling: Mechanisms of Initiation and Propagation
- (2018) Adam H. Courtney et al. TRENDS IN BIOCHEMICAL SCIENCES
- Langerhans Cells Prevent Autoimmunity via Expansion of Keratinocyte Antigen-Specific Regulatory T Cells
- (2018) Daniela Y. Kitashima et al. EBioMedicine
- A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
- (2018) Laurence B. Peterson et al. JOURNAL OF AUTOIMMUNITY
- IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells
- (2018) Natasha C. Ward et al. JOURNAL OF IMMUNOLOGY
- Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
- (2018) Michael M. Boyiadzis et al. Journal for ImmunoTherapy of Cancer
- Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
- (2017) Megan Lo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia
- (2017) Liuluan Zhu et al. Journal of Hematology & Oncology
- Deal watch: IL-2 focus switches to stimulating Tregs
- (2017) Megan Cully NATURE REVIEWS DRUG DISCOVERY
- Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
- (2017) Rodrigo Vazquez-Lombardi et al. Nature Communications
- Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
- (2017) Christian Klein et al. OncoImmunology
- Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy
- (2017) Deborah Charych et al. PLoS One
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- Regulatory T cells delay disease progression in Alzheimer-like pathology
- (2016) Cira Dansokho et al. BRAIN
- Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
- (2016) Ajjai Alva et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- Restoring regulation – IL-2 therapy in systemic lupus erythematosus
- (2016) Jens Y. Humrich et al. Expert Review of Clinical Immunology
- Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer
- (2016) Arturo Valle-Mendiola et al. MEDIATORS OF INFLAMMATION
- An essential role for the IL-2 receptor in Treg cell function
- (2016) Takatoshi Chinen et al. NATURE IMMUNOLOGY
- Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
- (2016) Jing He et al. NATURE MEDICINE
- IL2Rβ-dependent signals drive terminal exhaustion and suppress memory development during chronic viral infection
- (2016) Jean-Christophe Beltra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
- (2016) N. Arenas-Ramirez et al. Science Translational Medicine
- Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
- (2016) John A. Todd et al. PLOS MEDICINE
- Spontaneous Resolution of Acute Rejection and Tolerance Induction With IL-2 Fusion Protein in Vascularized Composite Allotransplantation
- (2015) R. Jindal et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3+ T cells
- (2015) Florencia B. González et al. BRAIN BEHAVIOR AND IMMUNITY
- Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
- (2015) Riccardo Danielli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Emerging Roles of CCCH-Type Zinc Finger Proteins in Destabilizing mRNA Encoding Inflammatory Factors and Regulating Immune Responses
- (2015) Chuanbin Yang et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
- (2015) Jamie B. Spangler et al. IMMUNITY
- Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
- (2015) Suman Mitra et al. IMMUNITY
- Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells
- (2015) Charles J.M. Bell et al. JOURNAL OF AUTOIMMUNITY
- NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
- (2015) Michel M van den Heuvel et al. Journal of Translational Medicine
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
- (2014) A. A. Kennedy-Nasser et al. CLINICAL CANCER RESEARCH
- IL-2 Phosphorylates STAT5 To Drive IFN- Production and Activation of Human Dendritic Cells
- (2014) F. Herr et al. JOURNAL OF IMMUNOLOGY
- Identification of STAT5A and STAT5B Target Genes in Human T Cells
- (2014) Takahiro Kanai et al. PLoS One
- Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
- (2014) Emeline Castela et al. JAMA Dermatology
- A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
- (2013) Joseph P Connor et al. BMC CANCER
- Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity
- (2013) Kevin Goudy et al. CLINICAL IMMUNOLOGY
- Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
- (2013) Audrey Baeyens et al. DIABETES
- Regulation of Foxp3+ Inducible Regulatory T Cell Stability by SOCS2
- (2013) C. A. Knosp et al. JOURNAL OF IMMUNOLOGY
- Active STAT5 Regulates T-bet and Eomesodermin Expression in CD8 T Cells and Imprints a T-bet-Dependent Tc1 Program with Repressed IL-6/TGF- 1 Signaling
- (2013) M. Grange et al. JOURNAL OF IMMUNOLOGY
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein
- (2013) Julien Laurent et al. Journal of Translational Medicine
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Role of Cytokines in Thymus- Versus Peripherally Derived-Regulatory T Cell Differentiation and Function
- (2013) Jérémie David Goldstein et al. Frontiers in Immunology
- Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
- (2012) Mark R. Albertini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytokine Therapy With Interleukin-2/Anti–Interleukin-2 Monoclonal Antibody Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and Progression of Atherosclerosis
- (2012) Tam Nguyen Dinh et al. CIRCULATION
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours
- (2012) Silke Gillessen et al. EUROPEAN JOURNAL OF CANCER
- Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
- (2012) André Ballesteros-Tato et al. IMMUNITY
- Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates
- (2012) Timothy Millington et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Interleukin-2 Production by Dendritic Cells and its Immuno-Regulatory Functions
- (2012) Teresa Zelante et al. Frontiers in Immunology
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
- (2011) T. K. Eigentler et al. CLINICAL CANCER RESEARCH
- Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic Dermatitis
- (2011) Alon Y. Hershko et al. IMMUNITY
- CD4+CD25+Foxp3+ Regulatory T Cells Promote Th17 Cells In Vitro and Enhance Host Resistance in Mouse Candida albicans Th17 Cell Infection Model
- (2011) Pushpa Pandiyan et al. IMMUNITY
- T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells
- (2011) Guoyan Cheng et al. IMMUNOLOGICAL REVIEWS
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages
- (2011) Wei Liao et al. NATURE IMMUNOLOGY
- Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
- (2011) Xiang-Ping Yang et al. NATURE IMMUNOLOGY
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- Prolonged Interleukin-2Rα Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo
- (2010) Vandana Kalia et al. IMMUNITY
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
- (2010) Matthew E. Pipkin et al. IMMUNITY
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
- (2010) Yenkel Grinberg-Bleyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-2 mRNA Stabilization upon PMA Stimulation Is Dependent on NF90-Ser647 Phosphorylation by Protein Kinase C I
- (2010) P. Zhu et al. JOURNAL OF IMMUNOLOGY
- Paradoxical glomerular filtration of carbon nanotubes
- (2010) A. Ruggiero et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor subunit CD25
- (2010) S. Letourneau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
- (2010) C. Krieg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments
- (2010) D. Busse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine-Producing Effector B Cells Regulate Type 2 Immunity to H. polygyrus
- (2009) Wojciech Wojciechowski et al. IMMUNITY
- A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells
- (2009) Aixin Yu et al. IMMUNITY
- The T-cell-receptor signaling network
- (2009) M. Huse JOURNAL OF CELL SCIENCE
- In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
- (2009) Kylie E. Webster et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engineered Interleukin-2 Antagonists for the Inhibition of Regulatory T Cells
- (2009) David V. Liu et al. JOURNAL OF IMMUNOTHERAPY
- Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function
- (2009) Maciej Kmieciak et al. Journal of Translational Medicine
- Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation
- (2009) R. J. Johnston et al. SCIENCE
- Janus-Kinase-3-Dependent Signals Induce Chromatin Remodeling at the Ifng Locus during T Helper 1 Cell Differentiation
- (2008) Min Shi et al. IMMUNITY
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
- Primary Immune Deficiency Disorders Presenting as Autoimmune Diseases: IPEX and APECED
- (2008) D. Moraes-Vasconcelos et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Priming for T helper type 2 differentiation by interleukin 2–mediated induction of interleukin 4 receptor α-chain expression
- (2008) Wei Liao et al. NATURE IMMUNOLOGY
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now